Movement Alert|3SBio Falls 5.49% in Regular Trading, Trading at 17.06 HKD

Market Focus07-14

On July 14, 3SBio fell 5.49% in regular trading, trading at 17.06 HKD/share, with turnover of 184 million HKD.

Within the Biotechnology sector where 3SBio belongs, the overall sector trended weak. Among individual stocks, Innovent Bio down 0.51%, BeiGene down 0.86%, Akeso down 1.73%, SKB Bio down 2.06%, RemeGen down 3.43%.

3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. Its major products include TPIAO, EPIAO, YISAIPU and other biologics, as well as CDMO services. The company's products are mainly used in chemotherapy-induced thrombocytopenia, chronic kidney disease anemia, ankylosing spondylitis and psoriasis, with operations in both domestic and overseas markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment